Chronic Myeloid Leukemia Treatment Market, Global Outlook and Forecast 2022-2028
Chronic myeloid leukemia (CML) is a type of cancer that starts in certain blood-forming cells of the bone marrow. It most commonly occurs in the adults and very rarely it occurs in children. Chronic myeloid leukemia usually begins after age 60. CML is develop slowly and treated with targeted cancer drugs such as tyrosine kinase inhibitors, chemotherapy or a bone marrow transplant. Recent advances in cancer treatments has drastically improved the survival rate for this type of leukemia.
This report contains market size and forecasts of Chronic Myeloid Leukemia Treatment in global, including the following market information:
Global Chronic Myeloid Leukemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Myeloid Leukemia Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chronic Myeloid Leukemia Treatment companies in 2021 (%)
The global Chronic Myeloid Leukemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Myeloid Leukemia Treatment include Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.) and Lupin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Myeloid Leukemia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Myeloid Leukemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, by Type, 2021 (%)
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, by Application, 2021 (%)
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Chronic Myeloid Leukemia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Myeloid Leukemia Treatment revenues share in global market, 2021 (%)
Key companies Chronic Myeloid Leukemia Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chronic Myeloid Leukemia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Chronic Myeloid Leukemia Treatment in global, including the following market information:
Global Chronic Myeloid Leukemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Myeloid Leukemia Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chronic Myeloid Leukemia Treatment companies in 2021 (%)
The global Chronic Myeloid Leukemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Myeloid Leukemia Treatment include Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb Company, Pfizer Inc., Takeda Pharmaceutical Company Limited, Innovent Biologics, Inc., Viatris Inc. (Mylan N.V.) and Lupin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Myeloid Leukemia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Myeloid Leukemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, by Type, 2021 (%)
- Tablet
- Solution
- Capsule
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Chronic Myeloid Leukemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Chronic Myeloid Leukemia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Myeloid Leukemia Treatment revenues share in global market, 2021 (%)
Key companies Chronic Myeloid Leukemia Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chronic Myeloid Leukemia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva Pharmaceutical Industries Ltd
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Innovent Biologics, Inc.
- Viatris Inc. (Mylan N.V.)
- Lupin
- IL-YANG PHARM CO. LTD.
- Million Health Pharmaceuticals
- Celon Labs
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Chronic Myeloid Leukemia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Myeloid Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHRONIC MYELOID LEUKEMIA TREATMENT OVERALL MARKET SIZE
2.1 Global Chronic Myeloid Leukemia Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Myeloid Leukemia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chronic Myeloid Leukemia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chronic Myeloid Leukemia Treatment Players in Global Market
3.2 Top Global Chronic Myeloid Leukemia Treatment Companies Ranked by Revenue
3.3 Global Chronic Myeloid Leukemia Treatment Revenue by Companies
3.4 Global Chronic Myeloid Leukemia Treatment Sales by Companies
3.5 Global Chronic Myeloid Leukemia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chronic Myeloid Leukemia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chronic Myeloid Leukemia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Chronic Myeloid Leukemia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chronic Myeloid Leukemia Treatment Market Size Markets, 2021 & 2028
4.1.2 Tablet
4.1.3 Solution
4.1.4 Capsule
4.2 By Type - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
4.2.1 By Type - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
4.3.1 By Type - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
4.3.2 By Type - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
4.3.3 By Type - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Chronic Myeloid Leukemia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chronic Myeloid Leukemia Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
5.2.1 By Application - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
5.3.1 By Application - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
5.3.2 By Application - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
5.3.3 By Application - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Chronic Myeloid Leukemia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chronic Myeloid Leukemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
6.2.1 By Region - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
6.3.1 By Region - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
6.3.2 By Region - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
6.3.3 By Region - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.4.3 US Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.4 Canada Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.5 Mexico Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.5.3 Germany Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.4 France Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.5 U.K. Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.6 Italy Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.7 Russia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.9 Benelux Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.6.3 China Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.4 Japan Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.5 South Korea Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.7 India Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.7.3 Brazil Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.7.4 Argentina Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.8.3 Turkey Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.4 Israel Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.6 UAE Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 F. Hoffmann-La Roche Ltd. Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Major Product Offerings
7.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Corporate Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Bristol-Myers Squibb Company Key News
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Inc. Key News
7.6 Takeda Pharmaceutical Company Limited
7.6.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.6.2 Takeda Pharmaceutical Company Limited Business Overview
7.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Company Limited Key News
7.7 Innovent Biologics, Inc.
7.7.1 Innovent Biologics, Inc. Corporate Summary
7.7.2 Innovent Biologics, Inc. Business Overview
7.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.7.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Innovent Biologics, Inc. Key News
7.8 Viatris Inc. (Mylan N.V.)
7.8.1 Viatris Inc. (Mylan N.V.) Corporate Summary
7.8.2 Viatris Inc. (Mylan N.V.) Business Overview
7.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Major Product Offerings
7.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Viatris Inc. (Mylan N.V.) Key News
7.9 Lupin
7.9.1 Lupin Corporate Summary
7.9.2 Lupin Business Overview
7.9.3 Lupin Chronic Myeloid Leukemia Treatment Major Product Offerings
7.9.4 Lupin Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Lupin Key News
7.10 IL-YANG PHARM CO. LTD.
7.10.1 IL-YANG PHARM CO. LTD. Corporate Summary
7.10.2 IL-YANG PHARM CO. LTD. Business Overview
7.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 IL-YANG PHARM CO. LTD. Key News
7.11 Million Health Pharmaceuticals
7.11.1 Million Health Pharmaceuticals Corporate Summary
7.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Business Overview
7.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Major Product Offerings
7.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Million Health Pharmaceuticals Key News
7.12 Celon Labs
7.12.1 Celon Labs Corporate Summary
7.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Business Overview
7.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Major Product Offerings
7.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Celon Labs Key News
8 GLOBAL CHRONIC MYELOID LEUKEMIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chronic Myeloid Leukemia Treatment Production Capacity, 2017-2028
8.2 Chronic Myeloid Leukemia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Myeloid Leukemia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHRONIC MYELOID LEUKEMIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Chronic Myeloid Leukemia Treatment Industry Value Chain
10.2 Chronic Myeloid Leukemia Treatment Upstream Market
10.3 Chronic Myeloid Leukemia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Myeloid Leukemia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Chronic Myeloid Leukemia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Myeloid Leukemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL CHRONIC MYELOID LEUKEMIA TREATMENT OVERALL MARKET SIZE
2.1 Global Chronic Myeloid Leukemia Treatment Market Size: 2021 VS 2028
2.2 Global Chronic Myeloid Leukemia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chronic Myeloid Leukemia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Chronic Myeloid Leukemia Treatment Players in Global Market
3.2 Top Global Chronic Myeloid Leukemia Treatment Companies Ranked by Revenue
3.3 Global Chronic Myeloid Leukemia Treatment Revenue by Companies
3.4 Global Chronic Myeloid Leukemia Treatment Sales by Companies
3.5 Global Chronic Myeloid Leukemia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chronic Myeloid Leukemia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chronic Myeloid Leukemia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Chronic Myeloid Leukemia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Chronic Myeloid Leukemia Treatment Market Size Markets, 2021 & 2028
4.1.2 Tablet
4.1.3 Solution
4.1.4 Capsule
4.2 By Type - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
4.2.1 By Type - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
4.3.1 By Type - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
4.3.2 By Type - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
4.3.3 By Type - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Chronic Myeloid Leukemia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Chronic Myeloid Leukemia Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
5.2.1 By Application - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
5.3.1 By Application - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
5.3.2 By Application - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
5.3.3 By Application - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Chronic Myeloid Leukemia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Chronic Myeloid Leukemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Chronic Myeloid Leukemia Treatment Revenue & Forecasts
6.2.1 By Region - Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Chronic Myeloid Leukemia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Chronic Myeloid Leukemia Treatment Sales & Forecasts
6.3.1 By Region - Global Chronic Myeloid Leukemia Treatment Sales, 2017-2022
6.3.2 By Region - Global Chronic Myeloid Leukemia Treatment Sales, 2023-2028
6.3.3 By Region - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.4.3 US Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.4 Canada Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.4.5 Mexico Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.5.3 Germany Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.4 France Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.5 U.K. Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.6 Italy Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.7 Russia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.5.9 Benelux Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.6.3 China Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.4 Japan Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.5 South Korea Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.6.7 India Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.7.3 Brazil Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.7.4 Argentina Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, 2017-2028
6.8.3 Turkey Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.4 Israel Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
6.8.6 UAE Chronic Myeloid Leukemia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.1.2 Teva Pharmaceutical Industries Ltd Business Overview
7.1.3 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Major Product Offerings
7.1.4 Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Teva Pharmaceutical Industries Ltd Key News
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
7.2.3 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.2.4 F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 F. Hoffmann-La Roche Ltd. Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Chronic Myeloid Leukemia Treatment Major Product Offerings
7.3.4 Novartis AG Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Corporate Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Bristol-Myers Squibb Company Key News
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Corporate Summary
7.5.2 Pfizer Inc. Business Overview
7.5.3 Pfizer Inc. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.5.4 Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Inc. Key News
7.6 Takeda Pharmaceutical Company Limited
7.6.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.6.2 Takeda Pharmaceutical Company Limited Business Overview
7.6.3 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Takeda Pharmaceutical Company Limited Key News
7.7 Innovent Biologics, Inc.
7.7.1 Innovent Biologics, Inc. Corporate Summary
7.7.2 Innovent Biologics, Inc. Business Overview
7.7.3 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.7.4 Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Innovent Biologics, Inc. Key News
7.8 Viatris Inc. (Mylan N.V.)
7.8.1 Viatris Inc. (Mylan N.V.) Corporate Summary
7.8.2 Viatris Inc. (Mylan N.V.) Business Overview
7.8.3 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Major Product Offerings
7.8.4 Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Viatris Inc. (Mylan N.V.) Key News
7.9 Lupin
7.9.1 Lupin Corporate Summary
7.9.2 Lupin Business Overview
7.9.3 Lupin Chronic Myeloid Leukemia Treatment Major Product Offerings
7.9.4 Lupin Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Lupin Key News
7.10 IL-YANG PHARM CO. LTD.
7.10.1 IL-YANG PHARM CO. LTD. Corporate Summary
7.10.2 IL-YANG PHARM CO. LTD. Business Overview
7.10.3 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Major Product Offerings
7.10.4 IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 IL-YANG PHARM CO. LTD. Key News
7.11 Million Health Pharmaceuticals
7.11.1 Million Health Pharmaceuticals Corporate Summary
7.11.2 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Business Overview
7.11.3 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Major Product Offerings
7.11.4 Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.11.5 Million Health Pharmaceuticals Key News
7.12 Celon Labs
7.12.1 Celon Labs Corporate Summary
7.12.2 Celon Labs Chronic Myeloid Leukemia Treatment Business Overview
7.12.3 Celon Labs Chronic Myeloid Leukemia Treatment Major Product Offerings
7.12.4 Celon Labs Chronic Myeloid Leukemia Treatment Sales and Revenue in Global (2017-2022)
7.12.5 Celon Labs Key News
8 GLOBAL CHRONIC MYELOID LEUKEMIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Chronic Myeloid Leukemia Treatment Production Capacity, 2017-2028
8.2 Chronic Myeloid Leukemia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Myeloid Leukemia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 CHRONIC MYELOID LEUKEMIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Chronic Myeloid Leukemia Treatment Industry Value Chain
10.2 Chronic Myeloid Leukemia Treatment Upstream Market
10.3 Chronic Myeloid Leukemia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Myeloid Leukemia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Chronic Myeloid Leukemia Treatment in Global Market
Table 2. Top Chronic Myeloid Leukemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chronic Myeloid Leukemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chronic Myeloid Leukemia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Chronic Myeloid Leukemia Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Chronic Myeloid Leukemia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chronic Myeloid Leukemia Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Chronic Myeloid Leukemia Treatment Product Type
Table 9. List of Global Tier 1 Chronic Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 47. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 50. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offerings
Table 51. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Chronic Myeloid Leukemia Treatment Product Offerings
Table 54. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Company Corporate Summary
Table 56. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offerings
Table 57. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Inc. Corporate Summary
Table 59. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offerings
Table 60. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Takeda Pharmaceutical Company Limited Corporate Summary
Table 62. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offerings
Table 63. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Innovent Biologics, Inc. Corporate Summary
Table 65. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offerings
Table 66. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Viatris Inc. (Mylan N.V.) Corporate Summary
Table 68. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offerings
Table 69. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Lupin Corporate Summary
Table 71. Lupin Chronic Myeloid Leukemia Treatment Product Offerings
Table 72. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. IL-YANG PHARM CO. LTD. Corporate Summary
Table 74. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offerings
Table 75. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Million Health Pharmaceuticals Corporate Summary
Table 77. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offerings
Table 78. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Celon Labs Corporate Summary
Table 80. Celon Labs Chronic Myeloid Leukemia Treatment Product Offerings
Table 81. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Chronic Myeloid Leukemia Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Chronic Myeloid Leukemia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Chronic Myeloid Leukemia Treatment Production by Region, 2017-2022 (K Units)
Table 85. Global Chronic Myeloid Leukemia Treatment Production by Region, 2023-2028 (K Units)
Table 86. Chronic Myeloid Leukemia Treatment Market Opportunities & Trends in Global Market
Table 87. Chronic Myeloid Leukemia Treatment Market Drivers in Global Market
Table 88. Chronic Myeloid Leukemia Treatment Market Restraints in Global Market
Table 89. Chronic Myeloid Leukemia Treatment Raw Materials
Table 90. Chronic Myeloid Leukemia Treatment Raw Materials Suppliers in Global Market
Table 91. Typical Chronic Myeloid Leukemia Treatment Downstream
Table 92. Chronic Myeloid Leukemia Treatment Downstream Clients in Global Market
Table 93. Chronic Myeloid Leukemia Treatment Distributors and Sales Agents in Global Market
Table 1. Key Players of Chronic Myeloid Leukemia Treatment in Global Market
Table 2. Top Chronic Myeloid Leukemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Chronic Myeloid Leukemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Chronic Myeloid Leukemia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Chronic Myeloid Leukemia Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Chronic Myeloid Leukemia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Chronic Myeloid Leukemia Treatment Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Chronic Myeloid Leukemia Treatment Product Type
Table 9. List of Global Tier 1 Chronic Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Myeloid Leukemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Chronic Myeloid Leukemia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Chronic Myeloid Leukemia Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales, (K Units), 2023-2028
Table 46. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 47. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Product Offerings
Table 48. Teva Pharmaceutical Industries Ltd Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 50. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Product Offerings
Table 51. F. Hoffmann-La Roche Ltd. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Chronic Myeloid Leukemia Treatment Product Offerings
Table 54. Novartis AG Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Company Corporate Summary
Table 56. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Product Offerings
Table 57. Bristol-Myers Squibb Company Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Inc. Corporate Summary
Table 59. Pfizer Inc. Chronic Myeloid Leukemia Treatment Product Offerings
Table 60. Pfizer Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Takeda Pharmaceutical Company Limited Corporate Summary
Table 62. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Product Offerings
Table 63. Takeda Pharmaceutical Company Limited Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Innovent Biologics, Inc. Corporate Summary
Table 65. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Product Offerings
Table 66. Innovent Biologics, Inc. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Viatris Inc. (Mylan N.V.) Corporate Summary
Table 68. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Product Offerings
Table 69. Viatris Inc. (Mylan N.V.) Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Lupin Corporate Summary
Table 71. Lupin Chronic Myeloid Leukemia Treatment Product Offerings
Table 72. Lupin Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. IL-YANG PHARM CO. LTD. Corporate Summary
Table 74. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Product Offerings
Table 75. IL-YANG PHARM CO. LTD. Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Million Health Pharmaceuticals Corporate Summary
Table 77. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Product Offerings
Table 78. Million Health Pharmaceuticals Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Celon Labs Corporate Summary
Table 80. Celon Labs Chronic Myeloid Leukemia Treatment Product Offerings
Table 81. Celon Labs Chronic Myeloid Leukemia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Chronic Myeloid Leukemia Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Chronic Myeloid Leukemia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Chronic Myeloid Leukemia Treatment Production by Region, 2017-2022 (K Units)
Table 85. Global Chronic Myeloid Leukemia Treatment Production by Region, 2023-2028 (K Units)
Table 86. Chronic Myeloid Leukemia Treatment Market Opportunities & Trends in Global Market
Table 87. Chronic Myeloid Leukemia Treatment Market Drivers in Global Market
Table 88. Chronic Myeloid Leukemia Treatment Market Restraints in Global Market
Table 89. Chronic Myeloid Leukemia Treatment Raw Materials
Table 90. Chronic Myeloid Leukemia Treatment Raw Materials Suppliers in Global Market
Table 91. Typical Chronic Myeloid Leukemia Treatment Downstream
Table 92. Chronic Myeloid Leukemia Treatment Downstream Clients in Global Market
Table 93. Chronic Myeloid Leukemia Treatment Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Chronic Myeloid Leukemia Treatment Segment by Type
Figure 2. Chronic Myeloid Leukemia Treatment Segment by Application
Figure 3. Global Chronic Myeloid Leukemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Myeloid Leukemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Chronic Myeloid Leukemia Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Myeloid Leukemia Treatment Revenue in 2021
Figure 9. By Type - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chronic Myeloid Leukemia Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chronic Myeloid Leukemia Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 19. US Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 33. China Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chronic Myeloid Leukemia Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chronic Myeloid Leukemia Treatment by Region, 2021 VS 2028
Figure 50. Chronic Myeloid Leukemia Treatment Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Chronic Myeloid Leukemia Treatment Segment by Type
Figure 2. Chronic Myeloid Leukemia Treatment Segment by Application
Figure 3. Global Chronic Myeloid Leukemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Myeloid Leukemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Myeloid Leukemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Chronic Myeloid Leukemia Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chronic Myeloid Leukemia Treatment Revenue in 2021
Figure 9. By Type - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Chronic Myeloid Leukemia Treatment Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Chronic Myeloid Leukemia Treatment Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 19. US Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 33. China Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Chronic Myeloid Leukemia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Chronic Myeloid Leukemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Chronic Myeloid Leukemia Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Chronic Myeloid Leukemia Treatment by Region, 2021 VS 2028
Figure 50. Chronic Myeloid Leukemia Treatment Industry Value Chain
Figure 51. Marketing Channels
